BioSyent Declares First Quarter 2023 Dividend
February 01, 2023 16:30 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Feb. 01, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly...
BioSyent Signs Exclusive Agreement for Oncology Supportive Care Product
December 14, 2022 16:50 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Dec. 14, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its subsidiary, BioSyent Pharma Inc., has signed an...
BioSyent Announces Renewal of Normal Course Issuer Bid
December 13, 2022 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Dec. 13, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that the TSX Venture Exchange (“TSX-V”) has accepted the...
BioSyent Releases Q3 and YTD 2022 Financial Results
November 16, 2022 19:07 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Nov. 16, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three and nine months ended September 30, 2022. Key...
BioSyent Schedules Q3 and YTD 2022 Earnings Release for November 16, 2022
November 10, 2022 09:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Nov. 10, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and nine months ended...
BioSyent Initiates First Dividend
October 12, 2022 17:45 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Oct. 12, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly...
BioSyent to Present at the Virtual MicroCap Leadership Summit
September 14, 2022 16:30 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Sept. 14, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that it has been selected to present at the 7th annual...
BioSyent Announces Adoption of Dividend Policy
August 23, 2022 16:55 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Aug. 23, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors (the “Board”) today adopted a...
BioSyent Releases Q2 and H1 2022 Financial Results
August 23, 2022 16:45 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Aug. 23, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three and six months ended June 30, 2022. Key...
BioSyent Schedules Q2 and H1 2022 Earnings Release for August 23, 2022
August 16, 2022 19:14 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Aug. 16, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and six months ended June 30,...